Literature DB >> 22457163

Continuous 24-hour intraocular pressure monitoring for glaucoma--time for a paradigm change.

K Mansouri1, R Weinreb.   

Abstract

Glaucoma is the main cause of irreversible blindness and intraocular pressure (IOP) is its only modifiable risk factor. The importance of robust lowering of IOP for prevention of glaucoma onset and progression is well established. Although IOP is a dynamic parameter with individual circadian rhythms, current management usually relies on single IOP measurements during regular clinic hours performed a few times a year. Recent technological advances have provided clinicians with tools for continuous IOP monitoring during a 24 hour period in an ambulatory setting. There are two approaches being investigated. The first is permanent IOP monitoring through an implantable sensor and the other is temporary monitoring through a contact lens sensor. In this article, we discuss the shortcomings of the current gold standard for tonometry (Goldmann Applanation Tonometry) and the current experience with the first commercially available continuous 24 hour IOP monitoring technology (SENSIMED Triggerfish®); a telemetric contact lens sensor produced by a Swiss start-up company (Sensimed AG, Lausanne, Switzerland). Recent studies suggest that 24 hour continuous monitoring of IOP can be integrated into clinical practice and have the potential to contribute to the reduction of glaucoma-related vision loss.

Entities:  

Mesh:

Year:  2012        PMID: 22457163     DOI: 10.4414/smw.2012.13545

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  15 in total

1.  Effect of glaucoma medications on 24-hour intraocular pressure-related patterns using a contact lens sensor.

Authors:  Kaweh Mansouri; Felipe A Medeiros; Robert N Weinreb
Journal:  Clin Exp Ophthalmol       Date:  2015-08-16       Impact factor: 4.207

2.  Twenty-four-hour pattern of intraocular pressure in untreated patients with ocular hypertension.

Authors:  Tomas M Grippo; John H K Liu; Nazlee Zebardast; Taylor B Arnold; Grant H Moore; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-17       Impact factor: 4.799

Review 3.  Is 24-hour intraocular pressure monitoring necessary in glaucoma?

Authors:  Kaweh Mansouri; Robert N Weinreb; Felipe A Medeiros
Journal:  Semin Ophthalmol       Date:  2013-05       Impact factor: 1.975

4.  Analysis of continuous 24-hour intraocular pressure patterns in glaucoma.

Authors:  Kaweh Mansouri; John H K Liu; Robert N Weinreb; Ali Tafreshi; Felipe A Medeiros
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-13       Impact factor: 4.799

5.  Automated Detection and Quantification of Circadian Eye Blinks Using a Contact Lens Sensor.

Authors:  Christophe Gisler; Antonio Ridi; Jean Hennebert; Robert N Weinreb; Kaweh Mansouri
Journal:  Transl Vis Sci Technol       Date:  2015-01-22       Impact factor: 3.283

6.  Regulation of trabecular meshwork cell contraction and intraocular pressure by miR-200c.

Authors:  Coralia Luna; Guorong Li; Jianyong Huang; Jianming Qiu; Jing Wu; Fan Yuan; David L Epstein; Pedro Gonzalez
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

7.  Efficacy of a contact lens sensor for monitoring 24-h intraocular pressure related patterns.

Authors:  Kaweh Mansouri; Robert N Weinreb; John H K Liu
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

Review 8.  Novel therapies for open-angle glaucoma.

Authors:  Scott M Wentz; Nathaniel J Kim; Jenny Wang; Annahita Amireskandari; Brent Siesky; Alon Harris
Journal:  F1000Prime Rep       Date:  2014-11-04

Review 9.  New trends in glaucoma risk, diagnosis & management.

Authors:  Thomas Kersey; Colin I Clement; Phillip Bloom; M Francesca Cordeiro
Journal:  Indian J Med Res       Date:  2013-04       Impact factor: 2.375

10.  Reliable intraocular pressure measurement using automated radio-wave telemetry.

Authors:  Eleftherios I Paschalis; Fabiano Cade; Samir Melki; Louis R Pasquale; Claes H Dohlman; Joseph B Ciolino
Journal:  Clin Ophthalmol       Date:  2014-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.